CD14 and melanoma: Additionally, they showed that CD14+ cDC2s cells from melanoma patients had decreased T cell proliferation and activating capacity compared to canonical cDC2s [96], and blood CD14+ cDC2s (de facto DC3s) numbers relate to lower survival rates.